{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:39:06Z","timestamp":1789184346998,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.surg.2023.08.047","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T15:12:48Z","timestamp":1699715568000},"page":"743-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Validated predictive model for treatment and prognosis of adrenocortical carcinoma"],"prefix":"10.1016","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2747-0657","authenticated-orcid":false,"given":"Samuel M.","family":"Zuber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2484-6302","authenticated-orcid":false,"given":"Kristine","family":"Kuchta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5434-7067","authenticated-orcid":false,"given":"Simon A.","family":"Holoubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2322-2207","authenticated-orcid":false,"given":"Amna","family":"Khokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"Moo-Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Prinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8059-7828","authenticated-orcid":false,"given":"David J.","family":"Winchester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2023.08.047_bib1","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.ejca.2013.02.034","article-title":"Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993","volume":"49","author":"Kerkhofs","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.surg.2023.08.047_bib2","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","article-title":"Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?","volume":"30","author":"Kebebew","year":"2006","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2023.08.047_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jamcollsurg.2005.11.005","article-title":"Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?","volume":"202","author":"Sturgeon","year":"2006","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.surg.2023.08.047_bib4","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1210\/jc.2010-0803","article-title":"Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers","volume":"95","author":"Fassnacht","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2023.08.047_bib6","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/cncr.23886","article-title":"Adrenocortical carcinoma in the United States","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2023.08.047_bib7","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2023.08.047_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.beem.2008.10.008","article-title":"Clinical management of adrenocortical carcinoma","volume":"23","author":"Fassnacht","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2023.08.047_bib9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","article-title":"Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy","volume":"322","author":"Luton","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2023.08.047_bib10","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1210\/jcem.86.8.7780","article-title":"Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome","volume":"86","author":"Schteingart","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2023.08.047_bib11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamasurg.2022.3544","article-title":"American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive Summary","volume":"157","author":"Yip","year":"2022","journal-title":"JAMA Surgery"},{"key":"10.1016\/j.surg.2023.08.047_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.surg.2023.08.047_bib13","doi-asserted-by":"crossref","DOI":"10.21037\/amj.2020.01.07","article-title":"Systemic therapy for adrenocortical carcinoma: a review","volume":"5","author":"Hallanger-Johnson","year":"2020","journal-title":"AME Med J"},{"key":"10.1016\/j.surg.2023.08.047_bib14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/jc.2013-2856","article-title":"Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma","volume":"99","author":"Else","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2023.08.047_bib15","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2023.08.047_bib16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13014-020-01533-3","article-title":"Efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis","volume":"15","author":"Zhu","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.surg.2023.08.047_bib17","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/cncr.24331","article-title":"Radiotherapy in adrenocortical carcinoma","volume":"115","author":"Polat","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2023.08.047_bib18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1677\/erc.1.01029","article-title":"Management of patients with adrenal cancer: recommendations of an international consensus conference","volume":"12","author":"Schteingart","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.surg.2023.08.047_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1245\/s10434-009-0716-x","article-title":"Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane","volume":"17","author":"Grubbs","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2023.08.047_bib20","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2023.08.047_bib21","first-page":"377","article-title":"CAP (cyclophosphamide, doxorubicin, and cisplatin) regimen in adrenal cortical carcinoma","volume":"67","author":"van Slooten","year":"1983","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.surg.2023.08.047_bib22","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1159::AID-CNCR28>3.0.CO;2-R","article-title":"Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical\u00a0carcinoma: a Southwest Oncology Group Study","volume":"88","author":"Williamson","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2023.08.047_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1677\/erc.1.01025","article-title":"Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial","volume":"12","author":"Berruti","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.surg.2023.08.047_bib24","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1464-410X.2009.08660.x","article-title":"External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma","volume":"104","author":"Zini","year":"2009","journal-title":"BJU International"},{"key":"10.1016\/j.surg.2023.08.047_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamasurg.2015.4516","article-title":"Nomograms to predict recurrence-free and overall survival after curative resection of adrenocortical carcinoma","volume":"151","author":"Kim","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.surg.2023.08.047_bib26","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.2147\/CMAR.S187169","article-title":"Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma","volume":"10","author":"Li","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.surg.2023.08.047_bib27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40880-019-0426-0","article-title":"A\u00a0nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study","volume":"39","author":"Kong","year":"2019","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.surg.2023.08.047_bib28","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.3390\/cancers12092720","article-title":"Development and internal validation of a multivariable prediction model for adrenocortical-carcinoma-specific mortality","volume":"12","author":"Ettaieb","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.surg.2023.08.047_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/EJE-21-0510","article-title":"S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study","volume":"186","author":"Elhassan","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.surg.2023.08.047_bib30","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","article-title":"Using the National Cancer Database for outcomes research: a review","volume":"3","author":"Boffa","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.surg.2023.08.047_bib31","first-page":"1050","article-title":"Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989","volume":"114","author":"Hay","year":"1993","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2023.08.047_bib32","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1200\/JCO.2009.23.1860","article-title":"Practical application of a calculator for conditional survival in colon cancer","volume":"27","author":"Chang","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2023.08.047_bib33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archsurg.2011.2281","article-title":"Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer","volume":"147","author":"Katz","year":"2012","journal-title":"Arch Surg"},{"key":"10.1016\/j.surg.2023.08.047_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jss.2022.05.011","article-title":"Treatment differences for adrenocortical carcinoma by race and insurance status","volume":"280","author":"Holoubek","year":"2022","journal-title":"J\u00a0Surg Res"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606023006189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606023006189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:07:14Z","timestamp":1758539234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606023006189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0039606023006189"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2023.08.047","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validated predictive model for treatment and prognosis of adrenocortical carcinoma","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2023.08.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}